Notably, LiCl treatment of 3xTg-AD mice significantly reduces tau phosphorylation at several epitopes that are abnormally phosphorylated in AD brain, including Thr181, Ser202/Thr205 and Thr23117. This evidence concerns the gene MAPT and Alzheimer disease.